Moderna Inc

MRNA

$345.64

+288.7% (1 year change)

Market Cap

$130 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$54.21 - $342.51

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

217.14x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $130 Billion
Enterprise Value $122 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +288.7%
52-Week High $342.51
52-Week Low $54.21
Beta 0.94
Outstanding Shares 402 Million
Avg 30 Day Volume 18.3 Million

Valuation

P/E Ratio 217.14
PEG -20.05
Earnings per Share $1.49
Price to Sales Ratio 57.61
Price to Book Ratio 38.4
Revenue to Enterprise Value 44.76
EBIT to Enterprise Value 192.97
Total Debt to Enterprise Value 0.0
Debt to Equity 0.04

Profitability

Revenue $2.73 Billion
Gross Profit $2.53 Billion
EBIT $634 Million
Net Income $598 Million
Profit Margin 21.89%
Quarterly Earnings Growth (YoY) -1082.9%
Return on Equity 15.59%
Return on Assets 4.71%
Return on Invested Capital 14.9%

News

Cashing COVID-19 Vaccine - AstraZeneca Or Pfizer

Cashing COVID-19 Vaccine - AstraZeneca Or Pfizer

Today AstraZeneca plc (NASDAQ: AZN ) released its second-quarter earnings with updated sales numbers for its COVID-19 vaccine; when compared to the big mRNA players, the numbers looked rather pale....

Benzinga Benzinga, 1 day ago
FDA approves Moderna, Pfizer vaccines for use in Ghana

FDA approves Moderna, Pfizer vaccines for use in Ghana

The Food and Drug Authority (FDA) has approved two more Covid-19 vaccines for use in Ghana. The approval will allow Modena (Spikevax) and Pfizer-BioNtech (Comirnaty) to be imported and distributed ...

News On Ghana News On Ghana, 2 days ago
Korea says Moderna will resume shipments next week

Korea says Moderna will resume shipments next week

Korea said Wednesday that Moderna was set to make up for the shortfall in the July delivery of its COVID-19 vaccine to the country with shipments resuming in August. As a result of a teleconference...

The Korea Herald The Korea Herald, 3 days ago